170 related articles for article (PubMed ID: 12199685)
1. Desmopressin is not always effective in mild haemophilia A patients undergoing urological surgery: the need of standardized protocols.
Renom P; Wibaut B; Rigot JM; Coupez B; Goudemand J
Haemophilia; 2002 Sep; 8(5):711-4. PubMed ID: 12199685
[TBL] [Abstract][Full Text] [Related]
2. The treatment of haemophilia, including prophylaxis, constant infusion and DDAVP.
Berntorp E
Baillieres Clin Haematol; 1996 Jun; 9(2):259-71. PubMed ID: 8800504
[TBL] [Abstract][Full Text] [Related]
3. Convulsions and respiratory arrest in association with desmopressin administration for the treatment of a bleeding tonsil in a child with borderline haemophilia.
Francis JD; Leary T; Niblett DJ
Acta Anaesthesiol Scand; 1999 Sep; 43(8):870-3. PubMed ID: 10492420
[TBL] [Abstract][Full Text] [Related]
4. Peri-operative desmopressin combined with pharmacokinetic-guided factor VIII concentrate in non-severe haemophilia A patients.
Romano LGR; Schütte LM; van Hest RM; Meijer K; Laros-van Gorkom BAP; Nieuwenhuizen L; Eikenboom J; Heubel-Moenen FCJI; Uitslager N; Coppens M; Fijnvandraat K; Driessens MHE; Polinder S; Cnossen MH; Leebeek FWG; Mathôt RAA; Kruip MJHA;
Haemophilia; 2024 Mar; 30(2):355-366. PubMed ID: 38343113
[TBL] [Abstract][Full Text] [Related]
5. Desmopressin treatment combined with clotting factor VIII concentrates in patients with non-severe haemophilia A: protocol for a multicentre single-armed trial, the DAVID study.
Schütte LM; Cnossen MH; van Hest RM; Driessens MHE; Fijnvandraat K; Polinder S; Beckers EAM; Coppens M; Eikenboom J; Laros-van Gorkom BAP; Meijer K; Nieuwenhuizen L; Mauser-Bunschoten EP; Leebeek FWG; Mathôt RAA; Kruip MJHA
BMJ Open; 2019 Apr; 9(4):e022719. PubMed ID: 31015264
[TBL] [Abstract][Full Text] [Related]
6. Desmopressin acetate as a haemostatic elevator in individuals with combined deficiency of factors V and VIII: a clinical trial.
Mansouritorghabeh H; Shirdel A
J Thromb Haemost; 2016 Feb; 14(2):336-9. PubMed ID: 26599105
[TBL] [Abstract][Full Text] [Related]
7. DDAVP (desmopressin; 1-deamino-cys-8-D-arginine-vasopressin) treatment in children with haemophilia B.
Ehl S; Severin T; Sutor AH
Br J Haematol; 2000 Dec; 111(4):1260-2. PubMed ID: 11167773
[TBL] [Abstract][Full Text] [Related]
8. Desmopressin for the treatment of haemophilia.
Castaman G
Haemophilia; 2008 Jan; 14 Suppl 1():15-20. PubMed ID: 18173690
[TBL] [Abstract][Full Text] [Related]
9. Mild haemophilia: a disease with many faces and many unexpected pitfalls.
Peerlinck K; Jacquemin M
Haemophilia; 2010 Jul; 16 Suppl 5():100-6. PubMed ID: 20590864
[TBL] [Abstract][Full Text] [Related]
10. Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin.
de la Fuente B; Kasper CK; Rickles FR; Hoyer LW
Ann Intern Med; 1985 Jul; 103(1):6-14. PubMed ID: 3923887
[TBL] [Abstract][Full Text] [Related]
11. 1-Deamino-8-d-arginine vasopressin: a new pharmacological approach to the management of haemophilia and von Willebrands' diseases.
Mannucci PM; Ruggeri ZM; Pareti FI; Capitanio A
Lancet; 1977 Apr; 1(8017):869-72. PubMed ID: 67283
[TBL] [Abstract][Full Text] [Related]
12. Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia.
Martinowitz U; Luboshitz J; Bashari D; Ravid B; Gorina E; Regan L; Stass H; Lubetsky A
Haemophilia; 2009 May; 15(3):676-85. PubMed ID: 19298381
[TBL] [Abstract][Full Text] [Related]
13. Continuous factor VIII infusion therapy in patients with haemophilia A undergoing surgical procedures with plasma-derived or recombinant factor VIII concentrates.
Dingli D; Gastineau DA; Gilchrist GS; Nichols WL; Wilke JL
Haemophilia; 2002 Sep; 8(5):629-34. PubMed ID: 12199670
[TBL] [Abstract][Full Text] [Related]
14. Adenotonsillectomy in patients with desmopressin responsive mild bleeding disorders: a review of the literature.
Dunn AL; Cox Gill J
Haemophilia; 2010 Sep; 16(5):711-6. PubMed ID: 20028423
[TBL] [Abstract][Full Text] [Related]
15. Response to desmopressin is strongly dependent on F8 gene mutation type in mild and moderate haemophilia A.
Stoof SC; Sanders YV; Petrij F; Cnossen MH; de Maat MP; Leebeek FW; Kruip MJ
Thromb Haemost; 2013 Mar; 109(3):440-9. PubMed ID: 23348756
[TBL] [Abstract][Full Text] [Related]
16. Desmopressin (DDAVP) for treatment of disorders of hemostasis.
Mannucci PM
Prog Hemost Thromb; 1986; 8():19-45. PubMed ID: 3104987
[TBL] [Abstract][Full Text] [Related]
17. Desmopressin: therapeutic limitations in children and adults with inherited coagulation disorders.
Nolan B; White B; Smith J; O'Reily C; Fitzpatrick B; Smith OP
Br J Haematol; 2000 Jun; 109(4):865-9. PubMed ID: 10929043
[TBL] [Abstract][Full Text] [Related]
18. [Desmopressin in hemophilia A and Von Willebrand's disease].
Castro Cabezas M; de Graaf JC; Kraayenhagen RJ; Freen M; Poortman J; Hart HC
Ned Tijdschr Geneeskd; 1991 Mar; 135(9):367-71. PubMed ID: 1901629
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin (dDAVP): a powerful general hemostatic agent?
Drouet L; Scrobohaci ML; Boudaoud S; Vilain G
Nouv Rev Fr Hematol (1978); 1989; 31(2):163-5. PubMed ID: 2528120
[No Abstract] [Full Text] [Related]
20. Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis.
Arshad F; Stoof SC; Leebeek FW; Ruitenbeek K; Adelmeijer J; Blokzijl H; van den Berg AP; Porte RJ; Kruip MJ; Lisman T
Liver Int; 2015 Jul; 35(7):1809-15. PubMed ID: 25522671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
